# AEON Biopharma

AEON Biopharma is an Asset Manager based in Irvine, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Irvine, United States
- **Region:** North America
- **Address:** Irvine, CA, United States
- **Assets under management:** Undisclosed
- **Website:** aeonbiopharma.com
- **LinkedIn:** https://www.linkedin.com/company/aeon-biopharma-inc

## Regulatory record

- **Reports private funds:** No

## About

AEON Biopharma develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions. It restricts activity to therapeutic uses and reviews additional indications through a product assessment process that weighs clinical, regulatory, and commercial factors.

## Sectors

- Biotechnology

## Questions

### What is AEON Biopharma's core therapeutic focus?

AEON Biopharma develops injectable botulinum toxin therapeutics for neurological conditions. Its lead candidate, ABP-450, targets chronic migraine and cervical dystonia. The company explicitly focuses on therapeutic neurology rather than aesthetic applications of botulinum toxin.

### Who runs investment decisions at AEON Biopharma?

AEON Biopharma does not function as an investment firm and has no external allocator function. Capital allocation decisions are corporate decisions made by management and the board, focused on clinical trial funding. The firm does not manage a portfolio of outside investments or external manager relationships.

### Does AEON Biopharma participate in fund commitments or direct investments?

No. AEON Biopharma is an operating company that deploys capital solely into its own clinical programs and corporate infrastructure. It does not make fund commitments, direct co-investments, or venture allocations as a principal.

### What is AEON Biopharma's known posture on co-investments alongside external GPs?

As a development-stage biotech company, AEON Biopharma has no co-investment program alongside external general partners. The firm's capital structure is that of an equity-financed operating company, not an institutional allocator, and no co-investment activity has been disclosed in public filings.

## Related profiles

- [New Zealand Energy Corp.](https://altss.com/profile/new-zealand-energy-corp)
- [Seneca Bancorp](https://altss.com/profile/seneca-bancorp-inc)

---

Last updated: 2026-07-11T16:12:37.000Z

Canonical page: https://altss.com/profile/aeon-biopharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology